IOVANCE BIOTHERAPEUTICS INC shareholders Q2 2023

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 219 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

IOVANCE BIOTHERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
SG Americas Securities, LLC 367,467$2,5870.02%
GREAT LAKES ADVISORS, LLC 284,181$2,000,6300.02%
CREDIT SUISSE AG/ 2,794,124$19,670,6330.02%
Renaissance Technologies 1,732,700$12,1980.02%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 530,142$3,732,2000.02%
PANAGORA ASSET MANAGEMENT INC 390,094$2,746,2620.02%
Sumitomo Mitsui Trust Holdings, Inc. 2,490,600$17,533,8240.01%
GTS SECURITIES LLC 62,523$440,1620.01%
TWO SIGMA ADVISERS, LP 802,700$5,651,0080.01%
Capula Management Ltd 81,520$573,9010.01%
Hudson Bay Capital Management LP 275,000$1,936,0000.01%
MILLENNIUM MANAGEMENT LLC 3,580,668$25,207,9030.01%
Virtu Financial LLC 21,851$1540.01%
Cubist Systematic Strategies, LLC 252,622$1,778,4590.01%
DEUTSCHE BANK AG\ 3,311,980$23,316,3400.01%
Jump Financial, LLC 42,430$298,7070.01%
TUDOR INVESTMENT CORP ET AL 115,277$811,5500.01%
Bank Pictet & Cie (Europe) AG 35,819$252,1660.01%
PRINCIPAL FINANCIAL GROUP INC 1,870,250$13,166,5620.01%
RMB Capital Management, LLC 34,791$244,9290.01%
External links

This page lists IOVANCE BIOTHERAPEUTICS INC's shareholders in Q2 2023. To view IOVANCE BIOTHERAPEUTICS INC's shareholder history, click here.